JP2019517597A5 - - Google Patents

Download PDF

Info

Publication number
JP2019517597A5
JP2019517597A5 JP2019517202A JP2019517202A JP2019517597A5 JP 2019517597 A5 JP2019517597 A5 JP 2019517597A5 JP 2019517202 A JP2019517202 A JP 2019517202A JP 2019517202 A JP2019517202 A JP 2019517202A JP 2019517597 A5 JP2019517597 A5 JP 2019517597A5
Authority
JP
Japan
Prior art keywords
composition
kit
administered
haf
injury
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019517202A
Other languages
English (en)
Japanese (ja)
Other versions
JP7126268B2 (ja
JP2019517597A (ja
Filing date
Publication date
Priority claimed from US15/290,271 external-priority patent/US20170354692A1/en
Application filed filed Critical
Publication of JP2019517597A publication Critical patent/JP2019517597A/ja
Publication of JP2019517597A5 publication Critical patent/JP2019517597A5/ja
Priority to JP2021137896A priority Critical patent/JP7371948B2/ja
Application granted granted Critical
Publication of JP7126268B2 publication Critical patent/JP7126268B2/ja
Priority to JP2023112316A priority patent/JP2023121866A/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019517202A 2016-06-13 2017-06-13 肺障害の処置のための羊水液剤 Expired - Fee Related JP7126268B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021137896A JP7371948B2 (ja) 2016-06-13 2021-08-26 肺障害の処置のための羊水液剤
JP2023112316A JP2023121866A (ja) 2016-06-13 2023-07-07 肺障害の処置のための羊水液剤

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662349352P 2016-06-13 2016-06-13
US62/349,352 2016-06-13
US15/290,271 US20170354692A1 (en) 2016-06-13 2016-10-11 Amniotic fluid formulation for treatment of lung disorders
US15/290,271 2016-10-11
PCT/US2017/037251 WO2017218535A1 (en) 2016-06-13 2017-06-13 Amniotic fluid formulation for treatment of lung disorders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021137896A Division JP7371948B2 (ja) 2016-06-13 2021-08-26 肺障害の処置のための羊水液剤

Publications (3)

Publication Number Publication Date
JP2019517597A JP2019517597A (ja) 2019-06-24
JP2019517597A5 true JP2019517597A5 (enExample) 2020-07-27
JP7126268B2 JP7126268B2 (ja) 2022-08-26

Family

ID=60572075

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019517202A Expired - Fee Related JP7126268B2 (ja) 2016-06-13 2017-06-13 肺障害の処置のための羊水液剤
JP2021137896A Active JP7371948B2 (ja) 2016-06-13 2021-08-26 肺障害の処置のための羊水液剤
JP2023112316A Pending JP2023121866A (ja) 2016-06-13 2023-07-07 肺障害の処置のための羊水液剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021137896A Active JP7371948B2 (ja) 2016-06-13 2021-08-26 肺障害の処置のための羊水液剤
JP2023112316A Pending JP2023121866A (ja) 2016-06-13 2023-07-07 肺障害の処置のための羊水液剤

Country Status (7)

Country Link
US (3) US20170354692A1 (enExample)
EP (1) EP3468571B1 (enExample)
JP (3) JP7126268B2 (enExample)
AU (1) AU2017283482B2 (enExample)
CA (1) CA3027489C (enExample)
ES (1) ES2912075T3 (enExample)
WO (1) WO2017218535A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5505760B2 (ja) 2005-09-27 2014-05-28 ティッシュテク・インコーポレーテッド 羊膜調製物及び精製組成物及びその使用方法
US9526770B2 (en) 2011-04-28 2016-12-27 Tissuetech, Inc. Methods of modulating bone remodeling
ES2846789T3 (es) 2012-07-11 2021-07-29 Tissuetech Inc Composiciones que contienen complejos HC-HA/PTX3 y métodos de uso de los mismos
WO2016111899A1 (en) * 2015-01-05 2016-07-14 Petrucci Gary M Methods and materials for treating lung disorders
US20160243288A1 (en) 2015-02-23 2016-08-25 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
US10342831B2 (en) 2015-05-20 2019-07-09 Tissuetech, Inc. Composition and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
WO2017062948A1 (en) * 2015-10-09 2017-04-13 Mam Holdings Of West Florida, Llc Amniotic fluid topical formulation for the treatment of eye disorders
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
US20180096104A1 (en) * 2016-10-05 2018-04-05 MED Inc. Disease management system
CN108434441A (zh) * 2018-04-17 2018-08-24 哈尔滨博翱生物医药技术开发有限公司 新型成纤维细胞生长因子-21类似物在治疗弥漫性间质性肺脏疾病中的应用
CN110812369A (zh) * 2018-08-10 2020-02-21 浙江楚沅生物科技有限公司 用于治疗组织坏死或改善心脏功能的药物
EP3858372A1 (en) * 2020-01-31 2021-08-04 AdVita Lifescience GmbH Human anti-inflammatory peptides for the inhalatory treatment of inflammatory pulmonary diseases
WO2021152119A1 (en) * 2020-01-31 2021-08-05 Advita Lifescience Gmbh Human anti-inflammatory peptides for the inhalatory treatment of inflammatory pulmonary diseases
CN113384300B (zh) * 2020-03-11 2022-05-20 肖娓珠 一种妇产科羊水取样保存装置
US20230135928A1 (en) * 2020-04-03 2023-05-04 University Of Utah Research Foundation Method for treating lung disease with cell-free amniotic fluid
US12377121B2 (en) 2020-04-10 2025-08-05 Zeo Scientifix, Inc. Compositions comprising nanoparticles, method of making and uses thereof
CA3204080A1 (en) * 2020-12-02 2022-06-09 Breathe Restore, Inc. Compositions, devices, and methods for treating respiratory disorders
EP4329834A4 (en) * 2021-04-27 2025-08-13 Avita Medical Americas Llc REGENERATIVE BIOACTIVE SUSPENSION DERIVED FROM FRESHLY DISAGGREGATED TISSUE AND METHODS OF USE IN CLINICAL THERAPIES
US12570949B2 (en) 2022-12-27 2026-03-10 AVITA Medical Americas, LLC Systems and devices for wound therapy and related methods of use
DE202023002794U1 (de) 2022-12-27 2024-07-15 AVITA Medical Americas, LLC Kassette zur Herstellung einer regenerativen epidermalen Suspension
US11944742B1 (en) * 2023-06-08 2024-04-02 Microneb Tech Holdings, Inc. Apparatus, methods, and systems for administering a medication to an animal
USD1112812S1 (en) 2023-12-22 2026-02-10 AVITA Medical Americas, LLC Tissue processing cartridge

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1699479A (en) 1928-04-27 1929-01-15 Lilly Co Eli Amniotic fluid and process of preparing it
US3752158A (en) 1970-11-23 1973-08-14 Snyder Manuf Co Inc Apparatus and method for suprapubic drainage of the urinary bladder
US4308875A (en) 1981-03-11 1982-01-05 Universal Medical Instrument Corporation Amniocentesis needle
US5436135A (en) 1985-09-02 1995-07-25 Pasteur Merieux Serums Et Vaccins New preparation of placenta collagen, their extraction method and their applications
US5219576A (en) 1988-06-30 1993-06-15 Collagen Corporation Collagen wound healing matrices and process for their production
US4977897A (en) 1988-08-17 1990-12-18 Robert Hurwitz Amniocentesis needle with improved sonographic visibility
US5000192A (en) 1990-01-02 1991-03-19 Sealfon Andrew I Prenatal specimen collection method
ATE276757T1 (de) 1995-06-07 2004-10-15 Organogenesis Inc Zusammensetzungen aus rekonstituierten kollagenfasersegmenten und verfahren zu ihrer herstellung
JP2731833B2 (ja) 1995-06-26 1998-03-25 大同ほくさん株式会社 海洋生物を原料とした代用皮膚
US7044945B2 (en) 2001-03-30 2006-05-16 Sand Bruce J Prevention of regression in thermal ciliary muscle tendinoplasty
WO2004026244A2 (en) 2002-09-18 2004-04-01 Emiliano Ghinelli Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin
US20050079147A1 (en) 2003-10-14 2005-04-14 Bernard Delaey Wound healing compositions and uses
WO2006091546A2 (en) 2005-02-22 2006-08-31 The Johns Hopkins School Of Medicine Use of amniotic fluid (af) in treating ocular disease and injury
EP1712220A1 (en) * 2005-04-15 2006-10-18 PARI GmbH Spezialisten für effektive Inhalation Pharmaceutical aerosol composition
WO2007009062A2 (en) 2005-07-13 2007-01-18 Anthrogenesis Corporation Treatment of leg ulcers using placenta derived collagen biofabric
US20080064098A1 (en) 2006-06-05 2008-03-13 Cryo-Cell International, Inc. Procurement, isolation and cryopreservation of maternal placental cells
US8071135B2 (en) 2006-10-04 2011-12-06 Anthrogenesis Corporation Placental tissue compositions
AU2007318210B2 (en) 2006-10-06 2014-02-20 Celularity Inc. Native (telopeptide) placental collagen compositions
US20090054350A1 (en) 2007-08-23 2009-02-26 Jean-Louis Tayot Process for the sterile concentration of collagen preparations, and collagen preparations obtained
EP2197270B8 (en) 2007-09-07 2020-03-04 Surgical Biologics, LLC Placental tissue grafts and improved methods of preparing and using the same
US9095569B2 (en) 2008-04-18 2015-08-04 Collplant Ltd. Methods of generating and using procollagen
US9162006B2 (en) 2009-06-16 2015-10-20 Baxter International Inc. Hemostatic sponge
US20120010727A1 (en) 2010-07-06 2012-01-12 AFcell Medical Amnion and chorion constructs and uses thereof in sport injury surgeries
WO2014072468A1 (en) * 2012-11-09 2014-05-15 Velin-Pharma A/S Compositions for pulmonary delivery
US10485521B2 (en) * 2013-05-10 2019-11-26 MAM Holdings of West Florida, L.L.C. Method for obtaining sterile human amniotic fluid and uses thereof
US20140336600A1 (en) 2013-05-10 2014-11-13 Carl Randall Harrell Method for Obtaining Sterile Human Amniotic Fluid and Uses Thereof
WO2015134936A1 (en) 2014-03-06 2015-09-11 Amnio Technology Llc Amnion derived therapeutic compositions and methods of use
US9132156B1 (en) * 2014-06-15 2015-09-15 Amnio Technology Llc Acellular amnion derived therapeutic compositions
WO2015134946A1 (en) * 2014-03-06 2015-09-11 Amnio Technology Llc Amnion derived therapeutic compositions and methods of use
KR20160001267A (ko) 2014-06-27 2016-01-06 삼성전자주식회사 커넥터 플러그 및 커넥터 소켓
US10517903B2 (en) 2015-09-14 2019-12-31 Amnio Technology Llc Amnion derived therapeutic composition and process of making same
US9579350B1 (en) 2016-02-25 2017-02-28 MAM Holdings of West Florida, L.L.C. Human amniotic fluid preparation having long-term stability
AU2017237093B2 (en) * 2016-03-23 2022-12-01 Mimedx Group, Inc. Compositions and methods of treatment with amniotic fluid

Similar Documents

Publication Publication Date Title
Lavorini et al. Dilemmas, confusion, and misconceptions related to small airways directed therapy
JP7371948B2 (ja) 肺障害の処置のための羊水液剤
CA2474479A1 (en) Composition for inhalation
JP2011520911A5 (enExample)
NZ585857A (en) Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
US12171788B2 (en) Methods and materials for treating lung disorders
JP2017503801A (ja) 小児における急性呼吸促迫症候群の治療のための吸入一酸化窒素ガスを使用する方法
RU2006132038A (ru) Комбинация (варианты) и фармацевтический препарат для лечения заболеваний дыхательных путей
CN101244063A (zh) 包含高效长效β2－激动剂和其它活性成分的药物组合物
JP2007520508A5 (enExample)
RU2006132036A (ru) Комбинация и фармацевтический препарат для лечения аллергий и заболеваний дыхательных путей
Popov et al. In vitro and in vivo evaluation of the efficacy and safety of powder hydroxypropylmethylcellulose as nasal mucosal barrier
JP2008533072A5 (enExample)
CN106488770A (zh) 用于治疗copd的福莫特罗和布地奈德的组合
GB2430623A (en) Medicaments for treating chronic respiratory disease
JP5501451B2 (ja) 咳の治療のためのテオブロミン
RU2010120806A (ru) Композиции для ингаляции, содержащие кислоту монтелукаст и ингибитор pde-4 или ингаляционный кортикостероид
JP2011500731A5 (enExample)
JP7369523B2 (ja) 中等度～重度のインフルエンザの処置
JP2020019721A (ja) 閉塞性気道疾患の抑制又は軽減のための組成物
US20150038719A1 (en) Agent for Ameliorating Chronic Obstructive Pulmonary Disease
CH717180B1 (de) Vasoaktives intestinales Peptid (VIP) zur Verwendung bei der Behandlung von medikamenteninduzierter Pneumonitis.
Herxheimer The protective action of antihistaminic and sympathomimetic aerosols in anaphylactic microshock of the guinea-pig
Castro et al. Asthma intervention research 2 (AIR2) trial
CN106727504A (zh) 辛伐他汀在制备预防高分压氧导致的肺型氧中毒的药物中的应用